Source link : https://newshealth.biz/health-news/datroway-gains-second-fda-nod-with-nsclc-approval/
The FDA has granted accelerated approval to datopotamab deruxtecan-dlnk (Datroway, Daiichi Sankyo) for certain patients with locally-advanced or metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer. Specifically, the Trop-2-directed antibody and topoisomerase inhibitor conjugate was approved for adults previously treated with an EGFR-directed therapy and platinum-based chemotherapy, according to the approval notice. The […]
The post Datroway Gains Second FDA Nod With NSCLC Approval first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-23 21:09:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8